about
Mouse Models in Prostate Cancer Translational Research: From Xenograft to PDXA novel CXCR4-targeted near-infrared (NIR) fluorescent probe (Peptide R-NIR750) specifically detects CXCR4 expressing tumorsCBX7 gene expression plays a negative role in adipocyte cell growth and differentiation.Vorinostat synergises with capecitabine through upregulation of thymidine phosphorylase.Adoptive immunotherapy with Cl-IB-MECA-treated CD8+ T cells reduces melanoma growth in miceNK1.1 cells and CD8 T cells mediate the antitumor activity of Cl-IB-MECA in a mouse melanoma model.Preclinical development of a novel class of CXCR4 antagonist impairing solid tumors growth and metastasesDissecting the role of curcumin in tumour growth and angiogenesis in mouse model of human breast cancerMorphine Promotes Tumor Angiogenesis and Increases Breast Cancer ProgressionInhibition of stromal CXCR4 impairs development of lung metastases.A novel multi-drug metronomic chemotherapy significantly delays tumor growth in mice.Panobinostat synergizes with zoledronic acid in prostate cancer and multiple myeloma models by increasing ROS and modulating mevalonate and p38-MAPK pathways.PATZ1 expression correlates positively with BAX and negatively with BCL6 and survival in human diffuse large B cell lymphomas.Anticancer and Anti-Inflammatory Properties of Ganoderma lucidum Extract Effects on Melanoma and Triple-Negative Breast Cancer Treatment.Role of Nigella sativa and Its Constituent Thymoquinone on Chemotherapy-Induced Nephrotoxicity: Evidences from Experimental Animal StudiesThe stress hormone norepinephrine increases migration of prostate cancer cells in vitro and in vivo.Antitumor activity of PEGylated biodegradable nanoparticles for sustained release of docetaxel in triple-negative breast cancer.Curcumin inhibits tumor growth and angiogenesis in an orthotopic mouse model of human pancreatic cancer.Novel metronomic chemotherapy and cancer vaccine combinatorial strategy for hepatocellular carcinoma in a mouse model.B cells contribute to the antitumor activity of CpG-oligodeoxynucleotide in a mouse model of metastatic lung carcinoma.CXCR4-antagonist Peptide R-liposomes for combined therapy against lung metastasis.HMGA2 cooperates with either p27(kip1) deficiency or Cdk4(R24C) mutation in pituitary tumorigenesis.Polyinosinic-polycytidylic acid limits tumor outgrowth in a mouse model of metastatic lung cancer.Inhibition of tumor growth by cancer vaccine combined with metronomic chemotherapy and anti-PD-1 in a pre-clinical setting.Microbiota effects on cancer: from risks to therapies.Loss of One or Two PATZ1 Alleles Has a Critical Role in the Progression of Thyroid Carcinomas Induced by the RET/PTC1 Oncogene.Unique true predicted neoantigens (TPNAs) correlates with anti-tumor immune control in HCC patientsPlasmacytoid Dendritic Cells Alter the Antitumor Activity of CpG-Oligodeoxynucleotides in a Mouse Model of Lung CarcinomaPlasmacytoid dendritic cells play a key role in tumor progression in lipopolysaccharide-stimulated lung tumor-bearing miceCharacterization of inflammatory infiltrate of ulcerative dermatitis in C57BL/6NCrl-Tg(HMGA1P6)1Pg mice
P50
Q26746524-0D4FDDA8-B398-4345-97EF-A6954A56F9D3Q33747260-A36BAD4F-9752-4D0B-A3FC-2747EDABE18AQ34178800-D0ED4FF8-72C2-4890-B07A-A352CB7C2A22Q34363544-23B7AEF2-25F6-47EE-9E78-7B2AFE4868B9Q34428963-456A959A-A07E-4B2A-BC96-A6164A848512Q34763695-D220C8EF-71E5-483F-B1C4-8B81EC5D4542Q34994758-935CF12F-A4F4-4E97-A453-45B6940EAABAQ35281792-BC60BBAF-C896-4C99-B209-C1FF990C184BQ35612450-B83EFF0D-3F29-4F24-8717-CAFDF8F7D837Q36250217-B5506D7B-BA4D-4E53-8A5F-B3647E882514Q36616446-918AE075-5719-4124-9332-22CAD2CB6A3CQ37577433-D0ACCBBE-1B97-468D-9379-2E5B19749365Q37644833-E2D1163E-8A01-4342-B788-575E71547992Q37729652-CEB1263B-B524-4C0A-909F-40F5F0B4B074Q38718953-7881A53C-60E9-4182-BCCD-AF8980AA7ACFQ38865724-4A7C7710-CA4D-4F1C-970A-2B978136287DQ38978377-9369B2C6-87F7-445A-A925-C7D1E80675B5Q39044826-5A78B0C8-7E98-4E0A-85E5-A782953D0E42Q41257562-4B415451-14F3-448C-A679-55973F0248FCQ44945891-8CFBF498-4381-43AB-8200-70FE62F1C71EQ45293948-D3DD2A07-92D6-44BF-9ACE-57D0668D796DQ47382950-F7D790BE-4C34-4F3C-B571-DC5898759C79Q47881125-072B3BAB-2CD8-4192-B619-835DC973F491Q48505173-B7774BDF-14CD-4932-8B6E-BE107BE08836Q54225597-AFC28B48-D7FE-4F59-8FEF-92C40854D00CQ55345025-CD707192-3A53-4A88-9253-CE23B618F194Q57810732-01DDD497-991C-49CD-B52C-22B5A1B92CB7Q61712181-6BF30E36-29A6-4121-8BCF-1E2D9F8FEE1BQ85969106-9DBFD211-A363-4E46-A318-DA66A8D6DE92Q90312428-F79D99A8-1496-4967-B428-31C95E3FA8F2
P50
description
researcher ORCID ID = 0000-0003-0183-6574
@en
wetenschapper
@nl
name
Antonio Luciano
@ast
Antonio Luciano
@en
Antonio Luciano
@es
Antonio Luciano
@nl
type
label
Antonio Luciano
@ast
Antonio Luciano
@en
Antonio Luciano
@es
Antonio Luciano
@nl
prefLabel
Antonio Luciano
@ast
Antonio Luciano
@en
Antonio Luciano
@es
Antonio Luciano
@nl
P106
P1153
36637763600
P21
P31
P496
0000-0003-0183-6574